Literature DB >> 27957160

Influence of Age and Gender on Complications of Catheter Ablation for Atrial Fibrillation.

Giuseppe Stabile1, Emanuele Bertaglia2, Carlo Pappone3, Sakis Themistoclakis4, Claudio Tondo5, Alessandro Zorzi2, Matteo Anselmino6.   

Abstract

BACKGROUND: Despite catheter ablation (CA) has become an accepted treatment option for symptomatic, drug-resistant atrial fibrillation (AF), safety of this procedure continues to be cause for concern.
OBJECTIVE: Aim of the present multicenter study was to assess the influence of age and gender on incidence and severity of early CA complications.
METHODS: From January 1, 2011 to December 31, 2011, data from 2,323 consecutive patients who underwent CA (mean age 59.1+10.9; 72.3% male) for AF in 29 Italian centres were collected. All complications occurring to the patients from admission to 30th post-procedural day were recorded.
RESULTS: Complications occurred in 94 patients (4.0%); of these 7 (0.30%) developed permanent sequelae. There was a significant trend toward a greater incidence of complications with increasing age-group. In particular, the incidence of complications was 35/1066 (3.3%) in patients <60 year-old vs 59/1257 (4.7%) in those > 60 year-old (p=0.03). All 7 patients with permanent sequeale were older than 60. Females had a higher incidence of complications both among younger [13/231 (5.6%) vs 22/915 (2.5%), p=0.02] and older patients [32/405 (7.9%) vs 27/739 (3.5%) p=0.001]. In subjects older than 60, 5/405 (1.2%) females and 2/176 (0.3%) males (p=0.04) suffered from permanent sequelae.
CONCLUSIONS: Older patients and females are a subgroup at higher risk of complications during AF ablation. A particular care should be taken when performing CA in this clinical setting.

Entities:  

Year:  2015        PMID: 27957160      PMCID: PMC4956359          DOI: 10.4022/jafib.1197

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  24 in total

1.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

Authors:  Hakan Oral; Carlo Pappone; Aman Chugh; Eric Good; Frank Bogun; Frank Pelosi; Eric R Bates; Michael H Lehmann; Gabriele Vicedomini; Giuseppe Augello; Eustachio Agricola; Simone Sala; Vincenzo Santinelli; Fred Morady
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

2.  Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Douglas Packer; Allan Skanes
Journal:  Circulation       Date:  2005-02-21       Impact factor: 29.690

3.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study).

Authors:  Giuseppe Stabile; Emanuele Bertaglia; Gaetano Senatore; Antonio De Simone; Franco Zoppo; Giovanni Donnici; Pietro Turco; Pietro Pascotto; Massimo Fazzari; Dino Franco Vitale
Journal:  Eur Heart J       Date:  2005-10-07       Impact factor: 29.983

4.  Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

Authors:  Riccardo Cappato; Hugh Calkins; Shih-Ann Chen; Wyn Davies; Yoshito Iesaka; Jonathan Kalman; You-Ho Kim; George Klein; Andrea Natale; Douglas Packer; Allan Skanes; Federico Ambrogi; Elia Biganzoli
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-12-07

5.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial.

Authors:  Oussama M Wazni; Nassir F Marrouche; David O Martin; Atul Verma; Mandeep Bhargava; Walid Saliba; Dianna Bash; Robert Schweikert; Johannes Brachmann; Jens Gunther; Klaus Gutleben; Ennio Pisano; Dominico Potenza; Raffaele Fanelli; Antonio Raviele; Sakis Themistoclakis; Antonio Rossillo; Aldo Bonso; Andrea Natale
Journal:  JAMA       Date:  2005-06-01       Impact factor: 56.272

6.  Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions.

Authors:  Edgar Argulian; Amar D Patel; Jerome L Abramson; Aniket Kulkarni; Kimberly Champney; Spencer Palmer; William Weintraub; Nanette K Wenger; Viola Vaccarino
Journal:  Am J Cardiol       Date:  2006-05-04       Impact factor: 2.778

7.  Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes.

Authors:  Pasquale Santangeli; Luigi Di Biase; Prasant Mohanty; J David Burkhardt; Rodney Horton; Rong Bai; Sanghamitra Mohanty; Agnes Pump; Douglas Gibson; Linda Couts; Richard Hongo; Salwa Beheiry; Andrea Natale
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-11

8.  Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications.

Authors:  Fred Kusumoto; Karin Prussak; Melissa Wiesinger; Tammy Pullen; Cynthia Lynady
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

9.  Significant gender-related differences in radiofrequency catheter ablation therapy.

Authors:  Nikolaos Dagres; Jonathan R Clague; Günter Breithardt; Martin Borggrefe
Journal:  J Am Coll Cardiol       Date:  2003-09-17       Impact factor: 24.094

10.  In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.

Authors:  Abhishek Deshmukh; Nileshkumar J Patel; Sadip Pant; Neeraj Shah; Ankit Chothani; Kathan Mehta; Peeyush Grover; Vikas Singh; Srikanth Vallurupalli; Ghanshyambhai T Savani; Apurva Badheka; Tushar Tuliani; Kaustubh Dabhadkar; George Dibu; Y Madhu Reddy; Asif Sewani; Marcin Kowalski; Raul Mitrani; Hakan Paydak; Juan F Viles-Gonzalez
Journal:  Circulation       Date:  2013-09-23       Impact factor: 29.690

View more
  1 in total

1.  Safety and Efficacy of Cryoballoon Ablation of Atrial Fibrillation in relation to the Patients' Age: Results from a Large Real-World Multicenter Observational Project.

Authors:  Luigi Sciarra; Saverio Iacopino; Giuseppe Arena; Claudio Tondo; Paolo Pieragnoli; Giulio Molon; Massimiliano Manfrin; Antonio Curnis; Antonio Dello Russo; Giovanni Rovaris; Giuseppe Stabile; Leonardo Calò; Gabriele Boscolo; Roberto Verlato
Journal:  Cardiol Res Pract       Date:  2021-12-28       Impact factor: 1.866

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.